Bio Path | DEBITO



DEBITO Cambiamento Data
Alterity Therapeutics Limited AUD 210.39K 120.67K 2023-06
Baxter International USD 9.71B 13M 2025-09
Cipla INR 4.38B 231.9M 2025-03
Clal Biotechnology ILS 35.76M 28.27M 2023-12
Compugen USD 2.95M 24K 2025-09
CSL USD 11.96B 219M 2024-12
Grifols EUR 9.23B 626.05M 2024-12
Karyopharm Therapeutics USD 264.09M 39.31M 2024-09


Bio Path DEBITO - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.